Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Treace Medical Concepts Inc., 3 years.
Treace Medical Concepts Inc.
Director
Neuronetics Inc.
Director
Xtant Medical Holdings Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Neuronetics Inc. May 25, 202396.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 15, 2026 | Xtant Medical Holdings Inc. | Grant or award | +215,517 | — | — |
| May 19, 2026 | Treace Medical Concepts Inc. | Grant or award | +30,000 | — | — |
| Nov 15, 2025 | Xtant Medical Holdings Inc. | Grant or award | +158,228 | — | — |
| May 20, 2025 | Treace Medical Concepts Inc. | Grant or award | +23,917 | — | — |
| Aug 15, 2024 | Xtant Medical Holdings Inc. | Grant or award | +162,162 | — | — |
| May 21, 2024 | Treace Medical Concepts Inc. | Grant or award | +15,091 | — | — |
| May 10, 2024 | Treace Medical Concepts Inc. | Open-market purchase | +130,000 | $4.57 | $594,100 |
| Aug 15, 2023 | Xtant Medical Holdings Inc. | Grant or award | +145,180 | — | — |
| May 25, 2023 | Neuronetics Inc. | Grant or award | +36,364 | — | — |
| May 24, 2023 | Neuronetics Inc. | Open-market sale | −14,400 | $2.70 | $38,880 |
| May 23, 2023 | Treace Medical Concepts Inc. | Grant or award | +2,753 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.